Johnston J D, Harvey C J, Menzies I S, Treacher D F
Department of Chemical Pathology, United Medical School, St. Thomas' Hospital, UK.
Crit Care Med. 1996 Jul;24(7):1144-9. doi: 10.1097/00003246-199607000-00013.
To assess gastrointestinal permeability and functional absorptive capacity in patients with sepsis.
Case control study to analyze gastrointestinal permeability and functional absorptive capacity of septic patients by differential saccharide absorption (from an oral test solution) and excretion.
The intensive Therapy Unit of St. Thomas' Hospital, London, UK.
Twenty patients with a mean Acute Physiology and Chronic Health Evaluation (APACHE) II score of 18.4 who were admitted to the intensive care unit with a diagnosis of sepsis. All patients were on enteral feeding. Patients with abdominal pathology were excluded.
An oral test solution containing 5 g of lactulose, 1 g of L-rhamnose, 0.5 g of D-xylose, and 0.2 g of 3-O-methyl-D-glucose dissolved in water to a final volume of 100 mL was administered to patients and controls. Urine was collected for 5 hrs starting immediately after administration of the test solution and the saccharide content of the urine was estimated and expressed as a percentage recovery of the oral test solution.
Septic patients had increased lactulose/L-rhamnose urine excretion ratios (0.23 +/- 0.19) compared with control subjects (0.03 +/- 0.01, p < .001), consistent with increased gastrointestinal permeability in sepsis. Septic patients had decreased L-rhamnose/3-O-methyl-D-glucose urine excretion ratios (0.14 +/- 0.07) compared with normal controls (0.28 +/- 0.08, p < .001), consistent with decreased gastrointestinal functional absorptive capacity in sepsis.
Patients with acute sepsis exhibit increased gastrointestinal permeability and decreased gastrointestinal functional absorptive capacity in comparison with healthy control subjects. These abnormalities may contribute to the pathophysiology of sepsis.
评估脓毒症患者的胃肠道通透性和功能性吸收能力。
病例对照研究,通过不同糖类吸收(来自口服测试溶液)和排泄分析脓毒症患者的胃肠道通透性和功能性吸收能力。
英国伦敦圣托马斯医院重症治疗科。
20例平均急性生理与慢性健康状况评分系统(APACHE)II评分为18.4的患者,因脓毒症诊断入住重症监护病房。所有患者均接受肠内喂养。排除有腹部病变的患者。
向患者和对照组给予一种口服测试溶液,该溶液含5g乳果糖、1g L-鼠李糖、0.5g D-木糖和0.2g 3-O-甲基-D-葡萄糖,溶于水至最终体积100mL。在给予测试溶液后立即开始收集5小时尿液,并测定尿液中的糖类含量,以口服测试溶液的回收率百分比表示。
与对照组(0.03±0.01,p<0.001)相比,脓毒症患者乳果糖/L-鼠李糖尿排泄率升高(0.23±0.19),这与脓毒症时胃肠道通透性增加一致。与正常对照组(0.28±0.08,p<0.001)相比,脓毒症患者L-鼠李糖/3-O-甲基-D-葡萄糖尿排泄率降低(0.14±0.07),这与脓毒症时胃肠道功能性吸收能力降低一致。
与健康对照者相比,急性脓毒症患者表现出胃肠道通透性增加和胃肠道功能性吸收能力降低。这些异常可能有助于脓毒症的病理生理学过程。